Theravance Biopharma, Inc.
TBPH
$18.43
-$1.18-6.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.69% | 158.92% | 48.11% | -3.30% | -4.91% |
| Total Receivables | -16.66% | 42.77% | -77.57% | 306.29% | 17.81% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.16% | 37.35% | -5.17% | -48.31% | -7.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.17% | 143.77% | -6.71% | 38.28% | -2.37% |
|
|
|||||
| Total Current Assets | -3.17% | 143.77% | -6.71% | 38.28% | -2.37% |
| Net Property, Plant & Equipment | -4.31% | -3.84% | -3.67% | -3.64% | -7.10% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.18% | -83.25% | 0.98% | -22.31% | -0.13% |
| Total Assets | -2.48% | 24.00% | -2.99% | -0.55% | -1.64% |
|
|
|||||
| Total Accounts Payable | 32.12% | -30.44% | 7.40% | 54.20% | -13.14% |
| Total Accrued Expenses | 31.50% | 23.58% | -6.36% | 17.56% | 6.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.17% | 0.82% | 0.89% | 155.29% | -0.55% |
| Total Finance Division Other Current Liabilities | -84.74% | 356.11% | 0.00% | -9.82% | 0.00% |
| Total Other Current Liabilities | -84.74% | 356.11% | 0.00% | -9.82% | 0.00% |
| Total Current Liabilities | -31.53% | 73.43% | -1.82% | 36.91% | 2.13% |
|
|
|||||
| Total Current Liabilities | -31.53% | 73.43% | -1.82% | 36.91% | 2.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.29% | -4.79% | -4.50% | -4.11% | -3.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.63% | 2.06% | 1.23% | 1.12% | 3.18% |
| Total Liabilities | -9.15% | 13.28% | -0.57% | 4.79% | 1.25% |
|
|
|||||
| Common Stock & APIC | 0.36% | 0.35% | 0.35% | 0.48% | 0.41% |
| Retained Earnings | 0.39% | 5.60% | -1.41% | -1.63% | -1.35% |
| Treasury Stock & Other | 420.00% | -- | -- | -86.00% | 327.27% |
| Total Common Equity | 3.48% | 35.46% | -5.45% | -5.45% | -4.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.48% | 35.46% | -5.45% | -5.45% | -4.15% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.48% | 35.46% | -5.45% | -5.45% | -4.15% |
|
|
|||||